Differentially expressed proteins in glioblastoma multiforme identified with a nanobody-based anti-proteome approach and confirmed by OncoFinder as possible tumor-class predictive biomarker candidates
1999 ◽
Vol 37
(2)
◽
pp. 115-121
◽
2020 ◽
Vol 79
(Suppl 1)
◽
pp. 178-179